Novo Nordisk says it has planned for all future ‘no-deal’ Brexit contingencies, including doubling UK stock to 16 weeks (around four months of supply), which will be in place by the end of January.
24th January 2019
Universities that do not improve on fulfilling their legal obligation to report clinical trials over the next six months could be brought in front of the House of Commons Science and Technology Committee to explain why they have failed to do so.
24th January 2019
NHS England has begun to roll out its NHS App to the public, in a move hailed by doctors' leaders as "a significant and constructive step forward in using technology to support patients".
24th January 2019
A 15-year-old boy with a rare brain tumour is set to begin innovative treatment at the NHS’s new Proton Beam Therapy centre, at The Christie hospital in Manchester.
23rd January 2019
The National Institute for Health and Care Excellence (NICE) has recommended digital cognitive behavioural therapy for use on the NHS in children and young people with mild depression.
23rd January 2019
Novo Nordisk has announced that Ozempic, a new once-weekly GLP-1 (human glucagon-like peptide-1) analogue injection for the treatment of type II diabetes, is now available in the UK.
23rd January 2019
GlaxoSmithKline has completed its acquisition of Tesaro, the oncology focused biopharmaceutical company.
23rd January 2019
Wren Therapeutics has announced the completion of a Series A financing round totalling £18 million.
23rd January 2019
Cancer Research UK has pledged to tackle global cancer challenges with £60 million funding.
23rd January 2019
Abcam has announced a research collaboration with the Loulou Foundation to discover new tools to advance research for the development of therapeutics for CDKL5 Deficiency Disorder.
22nd January 2019
NHS England's medical director has welcomed the introduction of stronger mental health safeguards for Superdrug's new high street botox plan.
22nd January 2019
The European Commission has expanded the use of Orkambi to include children with cystic fibrosis aged two years to five years.
22nd January 2019
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has given formal approval for Redx Pharma to re-commence a Phase I/IIa trial of experimental cancer therapy RXC004.
22nd January 2019
Scientists have uncovered 52 new genetic changes linked to osteoarthritis, doubling the number of genetic regions found to be associated with the disabling condition, potentially paving the way for the development of disease-modifying therapies.
22nd January 2019
With entries already surpassing the overall for last year, this year’s 20th anniversary edition of the competition is shaping up to be our largest one yet – so join your fellow peers and enter now!
22nd January 2019
